Member Exclusive News

The week in industry: New Drug Discovery Advisory Network established

Vertex Pharmaceuticals and Semma Therapeutics (both MA, USA) join to produce novel diabetes treatment, Processa Pharmaceuticals (MD, USA) to develop anti-fibrotic and muscular regeneration drug, breakthrough designation given to respiratory syncytial virus vaccine.

Go to the profile of RxNet
Sep 06, 2019
0
0

Please sign in or register for FREE

No comments yet.